Canadian Depo-Provera label updated with risk of BMD loss

Author：

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1060, 2005-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Depo-Provera may cause loss of bone mineral density

Reactions Weekly, Vol. 1, Iss. 1059, 2005-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Relative Cost Effectiveness of Depo-Provera ® , Implanon ® , and Mirena ® in Reversible Long-Term Hormonal Contraception in the UK

By Susan J. Varney Julian F. Guest

PharmacoEconomics, Vol. 22, Iss. 17, 2004-01 ,pp. : 1141-1151

Adis International

Access to resources Recommend Favorite

Canadian Permax label change: risk of cardiac valvulopathy

Reactions Weekly, Vol. 1, Iss. 1026, 2004-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Relenza label updated

Reactions Weekly, Vol. 1, Iss. 1197, 2008-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Inhaled triamcinolone associated with BMD loss

Reactions Weekly, Vol. 1, Iss. 1032, 2004-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite